Abstract:
BACKGROUND:The sequence and timing of taking migraine medications, whether prescription or over-the-counter, and the patient's response to their treatment, is unknown. OBJECTIVE:To describe the use of, response to, and satisfaction with acute medications for 1 migraine attack. METHODS:We performed a clinic-based survey of 127 patients at Jefferson Headache Center, Philadelphia. Adult patients who met the International Headache Society criteria for migraine with or without aura were included in the study. Patients were asked to complete a questionnaire. RESULTS:Of 109 participants who met the inclusion criteria, most waited 1 hour or more after the onset of symptoms to take medication. Triptans were most commonly used as first, second, and third medications. Triptan use was associated with higher 2-hour pain-free response rates compared with other agents, whether the triptan was used as the first, second, or third medication. Patients who were treated with medications other than triptans were more likely to have pain at 2 hours (P = .36). NSAIDs had relatively low pain-free and headache relief response rates at 2 hours. Sixty-two participants (56.9%) had to treat a second time and 31 (28.4%) had to treat a third time. Some participants (17.6%) had headache recurrence within 24 hours after becoming headache free following initial medication and some (23.5%) had recurrence after becoming headache free following their second medication. Sixty-six percent of participants reported being very satisfied/satisfied with their initial medication and 33% were somewhat dissatisfied/dissatisfied to some degree. Even though most patients were satisfied with their medication, 88% reported that they would be willing to try a new antimigraine medication. Most patients (60 [55%]) preferred a long-acting agent versus a rapid-onset, short-acting agent (which was preferred by 49 [45%] patients). CONCLUSION:Migraine patients have treatment preferences. They generally want a drug that provides complete headache relief, and they are often satisfied with the current treatment options.
journal_name
Headachejournal_title
Headacheauthors
Malik SN,Hopkins M,Young WB,Silberstein SDdoi
10.1111/j.1526-4610.2006.00437.xsubject
Has Abstractpub_date
2006-05-01 00:00:00pages
773-80issue
5eissn
0017-8748issn
1526-4610pii
HED437journal_volume
46pub_type
杂志文章相关文献
HEADACHE文献大全abstract::The responses in cervicogenic headache to four different agents have been studied. Nitroglycerin was given sublingually to 27 patients. Eighteen patients got more than 20% increase of their headache. Of those with any headache increase at all, 12 got bilateral and 12 unilateral pain. The typical late cluster headache ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed3305249.x
更新日期:1993-05-01 00:00:00
abstract:OBJECTIVE:Our study aims to examine factors related to access of triptans among multiple stakeholder groups. BACKGROUND:Triptans are a cornerstone of pain management for the acute treatment of migraine, but actual utilization of triptans is lower than ideal. Initial and continued access to triptans may be an important...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.12593
更新日期:2015-07-01 00:00:00
abstract::A patient with chronic daily headaches developed overt signs of Cushing syndrome during treatment with serial occipital nerve block injections. Investigation demonstrated an exogenous source of corticosteroids as the cause of the Cushing syndrome in this patient, thus, implicating the corticosteroid component of the o...
journal_title:Headache
pub_type: 杂志文章
doi:
更新日期:2001-10-01 00:00:00
abstract:BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intrav...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01510.x
更新日期:2009-11-01 00:00:00
abstract:OBJECTIVES:To provide a guide to the use and limitations of continuous opioid therapy (COT, or daily scheduled opioids) for refractory daily headache, based on the best available evidence and expert clinical experience. BACKGROUND:There has been a dramatic increase in opioid administration over the past 25 years, with...
journal_title:Headache
pub_type: 杂志文章,实务指引,评审
doi:10.1111/j.1526-4610.2010.01733.x
更新日期:2010-07-01 00:00:00
abstract:OBJECTIVE:To investigate the habituation response pattern of patients with migraine to a simple standard stressor and to a more complex performance-dependent (achievement) stressor in three peripheral systems (electrodermal, vasomotor, and cardiovascular). We hypothesized that the migraine patients would show abnormal ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2005.00270.x
更新日期:2005-11-01 00:00:00
abstract:BACKGROUND:Many children suffering from chronic headache and migraine present with comorbid functional disability, including physical, social, emotional, and academic activities. For children severely impaired by headache, intensive interdisciplinary pain rehabilitation treatment (IIPT) can improve functioning. However...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13389
更新日期:2018-11-01 00:00:00
abstract:OBJECTIVE:To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine. METHODS:Migraine patients were randomized 2:1 to double-...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/j.1526-4610.2010.01799.x
更新日期:2011-01-01 00:00:00
abstract::Life stress is found to be related to headache frequency in some studies, but not others. Research designs that find a relationship between the two tend to evaluate young subjects and employ large sample sizes. The purpose of this study was to evaluate the relationship between headache frequency and life stress, while...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.2000.00016.x
更新日期:2000-02-01 00:00:00
abstract::Greater occipital nerve (GON) infiltration is widely used for the treatment of primary and secondary headache disorders mainly on the basis of open-label evidence, although recent double-blinded placebo-controlled trials have demonstrated its efficacy in cluster headache. The procedure is generally well tolerated alth...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2012.02270.x
更新日期:2012-11-01 00:00:00
abstract:BACKGROUND:Despite the expanding therapeutic armamentarium, many people with episodic migraine (EM) have unmet acute treatment needs. OBJECTIVE:To determine the relative frequency of prespecified types of "unmet treatment needs" in persons with EM in a US population-based sample. METHODS:Eligible participants complet...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.12154
更新日期:2013-09-01 00:00:00
abstract::This multicenter, double-blind, clinical study was designed to compare the efficacy and safety of alpha-dihydroergocryptine and flunarizine in the prophylaxis of migraine without aura. One hundred thirty-five patients fulfilling the diagnostic criteria of the International Headache Society were enrolled at five neurol...
journal_title:Headache
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1046/j.1526-4610.1999.3906426.x
更新日期:1999-06-01 00:00:00
abstract:OBJECTIVE:This study aims to investigate the psychometric properties (component structure, reliability, and construct validity) of the Headache-Specific Locus of Control scale in several clinical migraine populations. BACKGROUND:Headache-specific locus of control beliefs may impact a person's behavioral decisions that...
journal_title:Headache
pub_type: 杂志文章,随机对照试验
doi:10.1111/head.13485
更新日期:2019-05-01 00:00:00
abstract::Forty out-patients affected by chronic tension-type headache were selected according to the diagnostic criteria of International Headache Society (IHS) Headache Classification Committee. In a controlled trial patients received placebo for a four-week baseline period, then they were randomized in double-blind fashion t...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1111/j.1526-4610.1994.hed3401044.x
更新日期:1994-01-01 00:00:00
abstract:OBJECTIVE:This cross-sectional study on a randomly drawn population sample of children and adolescents (n = 3399; aged 9 to 15) aimed at the assessment of patterns of associations between psychosocial variables and primary headache disorders like migraine (MIG) or tension-type headache. A headache-free group served as ...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2012.02210.x
更新日期:2012-10-01 00:00:00
abstract::Several clinical and circulatory physiological observations indicate that the internal carotid artery (ICA) with proximal pial and orbital-periorbital branches, as well as external carotid vessels adjacent to the orbital region, are involved in the autonomic symptoms of an attack of cluster headache. Evidence is prese...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.1991.hed3105314.x
更新日期:1991-05-01 00:00:00
abstract::A 6-year-old boy with a family history of hemiplegic migraine had a hemiplegic migraine lasting for 6 days complicated by prolonged fever, lethargy, and two brief focal seizures. An acute single photon emission computerized tomogram (SPECT) demonstrated decreased blood flow in the symptomatic cerebral hemisphere as we...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1997.3709590.x
更新日期:1997-10-01 00:00:00
abstract::A retrospective study was conducted on 1300 women suffering from migraine without aura referred to the Headache Centers of Parma and Pavia from 1984 to 1990. All the data concerning their reproductive life, and the modifications induced by it on the course of headache were obtained from record-charts. Migraine frequen...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.1993.hed3307385.x
更新日期:1993-07-01 00:00:00
abstract::Biomarkers are physical signs or laboratory measurements that occur in association with a pathological process and have putative diagnostic and/or prognostic utility. In migraine, clinical, radiological, and biochemical biomarkers might be helpful to improve diagnosis, get insight in pathophysiology, and facilitate tr...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2006.00499.x
更新日期:2006-07-01 00:00:00
abstract:BACKGROUND:Eletriptan is a potent 5-HT(1B/1D) agonist with proven efficacy in the acute treatment of migraine in adults. OBJECTIVE:To evaluate the efficacy and tolerability of eletriptan 40 mg versus placebo in adolescent patients (aged 12-17). METHODS:A multicenter, double-blind, parallel-group, placebo-controlled t...
journal_title:Headache
pub_type: 杂志文章,多中心研究,随机对照试验
doi:10.1111/j.1526-4610.2007.00755.x
更新日期:2007-04-01 00:00:00
abstract::Approximately 18% of all patients referred for a cranial computed tomography complain of headache only. We reviewed 363 consecutive patients in order to assess the value of this examination in the diagnostic approach. Despite the vast number of normal examinations (88.4%), we advocate the routine use of a cranial comp...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1996.3606347.x
更新日期:1996-06-01 00:00:00
abstract::Observations including the long-recognized tendency of migraine to run in families, the high concordance rates for migraine in twins reared together or apart, and the association of specific mutations with a rare migraine form are consistent with a genetic contribution to the disorder. This paper summarizes major find...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/j.1526-4610.2006.00486.x
更新日期:2006-06-01 00:00:00
abstract::In a period of one year (1990) we selected 40 patients suffering from migraine. For an open randomized study there were 2 groups of patients: the first were treated with 10mg of flunarizine per day and the second with 3 mg per day. The patients were treated for 4 months consecutively. There were 11 drop outs (27.5%): ...
journal_title:Headache
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1111/j.1526-4610.1992.hed3208390.x
更新日期:1992-09-01 00:00:00
abstract::Episodic cluster headache is a well-recognized entity usually starting in the second decade of life. Uncommonly, the first typical symptoms may present in the first decade of life, but are rarely recognized as such during childhood. We report a 12-year-old girl who presented with a 1-year history of bouts of right-sid...
journal_title:Headache
pub_type: 杂志文章
doi:10.1046/j.1526-4610.1997.3705296.x
更新日期:1997-05-01 00:00:00
abstract:OBJECTIVE:To evaluate the prevalence of migraine/severe headaches in those with and without general obesity and abdominal obesity (Abd-O) and the effect of gender and age on this relationship. BACKGROUND:General, or total body obesity (TBO), as estimated by body mass index, is a risk factor for migraine chronification...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/j.1526-4610.2009.01459.x
更新日期:2010-01-01 00:00:00
abstract:OBJECTIVE:To describe the relationship between mood/anxiety disorders and migraine headaches emphasizing the frequency of episodes based in a cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health. BACKGROUND:It has been suggested that frequency of migraine headaches can be directly associated wi...
journal_title:Headache
pub_type: 杂志文章,多中心研究
doi:10.1111/head.12397
更新日期:2014-09-01 00:00:00
abstract:BACKGROUND AND OBJECTIVES:Migraine headache is the seventh leading cause of disability worldwide causing adverse outcomes in many aspects of an individual's life. Many psychological aspects affect chronic migraine (CM): illness perception, anxiety, depressive symptoms, and job satisfaction. This observational study aim...
journal_title:Headache
pub_type: 杂志文章
doi:10.1111/head.13461
更新日期:2019-01-01 00:00:00
abstract:BACKGROUND:Lidocaine, an amide anesthetic, has been used in the treatment of a wide variety of pain disorders for over 75 years. In addition to pain control, lidocaine is an anti-arrhythmic agent and has anti-inflammatory properties. Lidocaine's unique properties, including nonlinear pharmacokinetics, have limited its ...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.13298
更新日期:2018-05-01 00:00:00
abstract:BACKGROUND:Persistent migraine aura without infarction (PMA) is a rare condition that is defined as an aura that lasts longer than 1 week in absence of infarction. Two types of PMA have been distinguished, notably persistent primary visual disturbance (PPVD) and typical aura (TA). OBJECTIVES:This case-based review art...
journal_title:Headache
pub_type: 杂志文章,评审
doi:10.1111/head.12392
更新日期:2014-09-01 00:00:00
abstract:BACKGROUND:Although naratriptan is not approved for prophylactic use in migraine, naratriptan has been shown to be significantly more effective than placebo for short-term prevention of menstrually related migraine (MRM). The tolerability of naratriptan administered intermittently for prophylaxis for MRM over the long ...
journal_title:Headache
pub_type: 临床试验,杂志文章
doi:10.1111/j.1526-4610.2007.00809.x
更新日期:2007-06-01 00:00:00